Holen Sie sich die Stockscreener-App
3.09
4.39%
0.13
Handel nachbörslich:
3.08
-0.010
-0.32%
Schlusskurs vom Vortag:
$2.96
Offen:
$2.96
24-Stunden-Volumen:
7.70M
Relative Volume:
1.80
Marktkapitalisierung:
$1.27B
Einnahmen:
$4.78B
Nettoeinkommen (Verlust:
$-284.68M
KGV:
-4.4783
EPS:
-0.69
Netto-Cashflow:
$-184.84M
1W Leistung:
+27.16%
1M Leistung:
+54.50%
6M Leistung:
-58.07%
1J Leistung:
-57.44%
1-Tages-Spanne:
$2.9428
$3.29
1-Wochen-Bereich:
$2.3766
$3.29
52-Wochen-Spanne:
$1.50
$7.73
Agilon Health Inc Stock (AGL) Company Profile
Firmenname
Agilon Health Inc
Sektor
Branche
Telefon
562-256-3800
Adresse
6210 E HWY 290, AUSTIN
Vergleichen Sie AGL mit anderen Aktien
| Aktien | Preis | Marktkapitalisierung | Umsatz | Nettogewinn | Free Cashflow | ENV |
|---|---|---|---|---|---|---|
AGL
Agilon Health Inc
|
3.09 | 1.27B | 4.78B | -284.68M | -184.84M | -0.69 |
|
HCA
Hca Healthcare Inc
|
310.45 | 78.64B | 69.62B | 5.93B | 5.88B | 22.27 |
|
DVA
Davita Inc
|
166.24 | 14.58B | 12.67B | 827.68M | 1.42B | 9.27 |
|
FMS
Fresenius Medical Care Ag Adr
|
23.07 | 13.54B | 20.87B | 715.14M | 1.67B | 1.2209 |
|
THC
Tenet Healthcare Corp
|
130.86 | 12.78B | 20.97B | 3.13B | 2.39B | 31.21 |
|
UHS
Universal Health Services Inc
|
184.80 | 12.19B | 15.42B | 1.03B | 956.84M | 15.02 |
Agilon Health Inc Stock (AGL) Upgrades & Downgrades
| Datum | Aktion | Analytiker | Ratingänderung |
|---|---|---|---|
| 2025-01-10 | Hochstufung | Citigroup | Sell → Neutral |
| 2025-01-10 | Eingeleitet | Needham | Hold |
| 2024-12-16 | Eingeleitet | Macquarie | Neutral |
| 2024-12-11 | Eingeleitet | Bernstein | Mkt Perform |
| 2024-11-11 | Herabstufung | JMP Securities | Mkt Outperform → Mkt Perform |
| 2024-11-08 | Herabstufung | William Blair | Outperform → Mkt Perform |
| 2024-10-30 | Herabstufung | Citigroup | Neutral → Sell |
| 2024-10-02 | Herabstufung | BofA Securities | Buy → Underperform |
| 2024-05-30 | Eingeleitet | Robert W. Baird | Neutral |
| 2024-04-22 | Eingeleitet | Citigroup | Neutral |
| 2024-03-06 | Eingeleitet | Barclays | Underweight |
| 2024-02-26 | Herabstufung | Jefferies | Buy → Hold |
| 2024-02-26 | Herabstufung | TD Cowen | Outperform → Market Perform |
| 2024-01-08 | Herabstufung | Leerink Partners | Outperform → Market Perform |
| 2024-01-08 | Herabstufung | Stifel | Buy → Hold |
| 2024-01-08 | Herabstufung | Wolfe Research | Outperform → Peer Perform |
| 2024-01-05 | Herabstufung | JP Morgan | Overweight → Neutral |
| 2024-01-05 | Herabstufung | Truist | Buy → Hold |
| 2023-12-11 | Herabstufung | Goldman | Buy → Neutral |
| 2023-12-06 | Eingeleitet | JMP Securities | Mkt Outperform |
| 2023-11-21 | Herabstufung | Deutsche Bank | Buy → Hold |
| 2023-10-20 | Eingeleitet | The Benchmark Company | Buy |
| 2023-06-13 | Eingeleitet | Evercore ISI | In-line |
| 2022-12-09 | Eingeleitet | Stifel | Buy |
| 2022-09-14 | Eingeleitet | RBC Capital Mkts | Outperform |
| 2022-09-12 | Eingeleitet | Goldman | Buy |
| 2022-09-07 | Fortgesetzt | Truist | Buy |
| 2022-06-24 | Eingeleitet | BTIG Research | Neutral |
| 2022-03-30 | Eingeleitet | Guggenheim | Buy |
| 2021-10-20 | Eingeleitet | Jefferies | Buy |
| 2021-09-27 | Eingeleitet | SVB Leerink | Outperform |
| 2021-09-10 | Eingeleitet | Cowen | Outperform |
| 2021-05-11 | Eingeleitet | William Blair | Outperform |
| 2021-05-10 | Eingeleitet | BofA Securities | Buy |
| 2021-05-10 | Eingeleitet | Deutsche Bank | Buy |
| 2021-05-10 | Eingeleitet | Goldman | Buy |
| 2021-05-10 | Eingeleitet | JP Morgan | Overweight |
| 2021-05-10 | Eingeleitet | Truist | Buy |
| 2021-05-10 | Eingeleitet | Wells Fargo | Overweight |
| 2021-05-10 | Eingeleitet | Wolfe Research | Outperform |
Alle ansehen
Agilon Health Inc Aktie (AGL) Neueste Nachrichten
agilon health validates InvestingPro's Fair Value analysis with 60% rally By Investing.com - Investing.com Canada
agilon health (NYSE:AGL) Trading Up 8.5% Following Analyst Upgrade - MarketBeat
Here’s Why Analysts Just Upgraded Agilon Health (AGL) - MSN
Market-Perform maintained for agilon health stock amid cash flow prudence - Investing.com India
Sanford C. Bernstein Forecasts Strong Price Appreciation for agilon health (NYSE:AGL) Stock - MarketBeat
Further Upside For agilon health, inc. (NYSE:AGL) Shares Could Introduce Price Risks After 29% Bounce - Simply Wall St
Intra-Cellular Therapies, Standard BioTools, SI-BONE And Other Big Stocks Moving Higher On Monday - Benzinga
Citi moves agilon health to Neutral rating, noting impact of favorable MA policies - Investing.com Australia
Citi moves agilon health to Neutral rating, noting impact of favorable MA policies By Investing.com - Investing.com South Africa
agilon health (NYSE:AGL) Trading Up 6.4%Time to Buy? - MarketBeat
Citigroup Upgrades agilon health (AGL) - MSN
Commit To Buy Agilon Health At $2, Earn 37.5% Using Options - Nasdaq
Agilon Health stock under scrutiny—margin recovery efforts yet to prove effective - Investing.com India
HIMS downgraded, agilon upgraded at Citi in 2025 Health Tech review - Seeking Alpha
Agilon Health stock under scrutiny—margin recovery efforts yet to prove effective By Investing.com - Investing.com South Africa
agilon health (NYSE:AGL) Earns Hold Rating from Analysts at Needham & Company LLC - MarketBeat
agilon health (NYSE:AGL) Shares Up 9.6%Here's What Happened - MarketBeat
Securities Class Action Alert: Wolf Haldenstein Adler Freeman & Herz LLP reminds investors that a securities class action lawsuit has been filed in the United States District Court for the Western District of Texas against agilon health, inc. - AccessWire
Short Interest in agilon health, inc. (NYSE:AGL) Declines By 6.7% - MarketBeat
agilon health, inc. (NYSE:AGL) Position Cut by Stifel Financial Corp - Defense World
Agilon Health, Inc, B. Riley Financial, Target Corporation, - GlobeNewswire
Agilon Health, Inc, B. Riley Financial, Target Corporation, and Getty Images Investigation Alert: Johnson Fistel, LLP Encourages Long-Term Investors to Reach Out for More Information - GlobeNewswire Inc.
agilon health, inc. (NYSE:AGL) Receives $4.28 Consensus Target Price from Analysts - MarketBeat
agilon health (NYSE:AGL) Trading Down 5.8%Here's Why - MarketBeat
agilon health Slides As Insider Purchases Lose Another US$50k - Simply Wall St
agilon health (NYSE:AGL) Trading 5% HigherWhat's Next? - MarketBeat
AGILON HEALTH INVESTIGATION INITIATED BY FORMER LOUISIANA ATTORNEY GENERAL: Kahn Swick & Foti, LLC Investigates the Officers and Directors of agilon health, inc.AGL - The Eastern Progress Online
agilon health (NYSE:AGL) Stock Price Down 7.8%Here's Why - MarketBeat
Forecasting The Future: 10 Analyst Projections For Agilon Health - Benzinga
agilon health, inc. (NYSE:AGL) Short Interest Update - MarketBeat
agilon health (NYSE:AGL) Now Covered by Analysts at Macquarie - MarketBeat
Macquarie starts agilon health at Neutral amid market challenges - Investing.com
Macquarie starts agilon health at Neutral amid market challenges By Investing.com - Investing.com South Africa
Agilon Health's SWOT analysis: stock faces challenges amid value-based care push - Investing.com
agilon health, inc. (NYSE:AGL) Director Purchases $55,000.00 in Stock - MarketBeat
Agilon Health director McLoughlin buys $55,084 in stock By Investing.com - Investing.com Canada
Agilon Health director McLoughlin buys $55,084 in stock - Investing.com India
Agilon Health director Silvana Battaglia acquires $50,269 in stock By Investing.com - Investing.com Australia
Agilon Health director Silvana Battaglia acquires $50,269 in stock - Investing.com
Bernstein Initiates Coverage of agilon health (AGL) with Market Perform Recommendation - MSN
Agilon health director Diana McKenzie buys $44,962 in common stock By Investing.com - Investing.com Nigeria
Agilon Health director Wulf John William buys $98,145 in stock By Investing.com - Investing.com Australia
Agilon Health director Wulf John William buys $98,145 in stock - Investing.com
Sanford C. Bernstein Initiates Coverage on agilon health (NYSE:AGL) - MarketBeat
Finanzdaten der Agilon Health Inc-Aktie (AGL)
Umsatz
Nettogewinn
Free Cashflow
ENV
4.36%
0.55%
In Yahoo öffnen
|
In Google öffnen
|
In Finviz öffnen
|
In MarketWatch öffnen
|
Öffnen Sie in EDGAR
|
Offen in Reuters
Kapitalisierung:
|
Volumen (24h):